Our researchers are based all over europe

The PhD students will be based in 7 research groups in Europe. The training network is coordinated by the University of Leeds in the UK, where three students will be based. It is funded by a Marie Skłodowska-Curie Early Training Network (ETN) grant. Two students will be based at the Leiden University Medical Center in the Netherlands, three at the Universitåtsklinikum in Essen, Germany, three at Lunds Universitet in Sweden, two at the Genome Research Limited at the Wellcome Trust Sanger Institute in the UK, and two at the University of Oslo in Norway. Two students will be funded by the Swiss Government but as part of the ETN.

Find out more about our researchers

Project Co-Ordinator

The MELGEN training network is coordinated by the Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds. The Scientific Coordinator is Professor Julia Newton Bishop working with Dr Juliette Randerson Moor.

  • Multi-Omics: a Revolutionary Approach to Data Analysis

    With the advent of advanced high-throughput technologies, researchers can now quantify the cellular changes at different molecular levels. Global examination of molecular levels comprises of analysing data integrated from multiple “omes” like genome, transcriptome, proteome, interactome, epigenome, metabolome, lipidome ,  and microbiome, referred to as Multi-omics. Multi-omics approach isRead More
  • MELGEN training in Leeds – version 2.0

    As part of the Marie Skłodowska-Curie Early Training Network, MELGEN fellows participate in seminars and workshops which boost up their scientific skills! Last May, we attended intense training activities at the gorgeous city of Camogli in Italy. MELGEN training was carried out in July in our coordinating place, Leeds,Read More
  • GenoMEL Annual Scientific Meeting and MELGEN Training 2017 in Italian Riviera

      Picturesque beauty of Italian Riviera welcomed GenoMEL members and 17 ESRs this year in the beautiful fishing village of Camogli, Genoa. The meeting returned to the place of its inception after 20 years and for this, a special thank goes to the GenoMEL members of University of Genoa.Read More
  • What are cancer immunotherapies?

    If you have read about cancer or even just watched the news, you are probably aware that the advent of immunotherapy has revolutionized the treatment paradigm of several solid tumors including melanoma. But what does it mean? Where does it come from? And How does it work?   CancerRead More
  • MELGEN researcher Sabrina Schindler awarded EADO poster prize in Athens

    One of our MELGEN researchers has received a prestigious award for her research! In May, Sabrina Schindler, a MELGEN researcher studying in Zurich, Switzerland, attended the 13th Congress of the European Association of Dermato Oncology held in Athens, Greece. Whilst there Sabrina presented a poster showing her research workRead More
  • 14th Annual Joint GenoMEL/BioGenoMEL/MELGEN Scientific Meeting 2017

    From the 15th to the 17th May 2017, the MELGEN researchers, together with their group leaders, will be gathering in Camogli, Italy to attend the 14th annual scientific meeting of the GenoMEL, BioGenoMEL and MELGEN consortia. Founded in 1997, the GenoMEL consortium was formed by a number of melanomaRead More